Odds Ratioa (95 % CI) | ||
---|---|---|
All Women (N = 732,430) | All Employeesb (N = 249,021) | |
Time Period | ||
Jan 1999–Dec 2000 | 0.28 (0.24 - 0.33)* | 0.24 (0.18 - 0.33)* |
Jan 2001–Jun 2006 | 1.00 | 1.00 |
Jul 2006–Dec 2012 | 3.66 (3.57 - 3.74)* | 3.63 (3.47 - 3.80)* |
Jan 2013–Mar 2014 | 6.61 (6.43 - 6.80)* | 6.73 (6.37 - 7.10)* |
Age group | ||
15–17 year old | 0.55 (0.53 - 0.58)* | - |
18–24 year old | 1.00 | 1.00 |
25–34 year old | 1.03 (1.00 - 1.05)* | 1.29 (1.22 - 1.37)* |
35–44 year old | 1.21 (1.18 - 1.24)* | 1.63 (1.54 - 1.73)* |
Region | ||
South | 1.00 | 1.00 |
Northeast | 0.80 (0.79 - 0.82)* | 0.88 (0.84 - 0.92)* |
Midwest | 0.90 (0.88 - 0.92)* | 0.97 (0.93 - 1.00) |
West | 1.27 (1.24 - 1.30)* | 1.29 (1.24 - 1.34)* |
Unknown region | 1.39 (1.35 - 1.44)* | 1.20 (1.12 - 1.29)* |
Plan type | ||
Point of Service (POS) | 1.00 | 1.00 |
Preferred Provider Organization (PPO) | 0.98 (0.95 - 1.01) | 0.89 (0.85 - 0.94)* |
Health Maintenance Organization (HMO) | 1.05 (1.03 - 1.08)* | 0.93 (0.90 - 0.97)* |
Indemnity | 1.14 (1.10 - 1.18)* | 1.04 (0.98 - 1.12) |
Unknown plan type | 1.21 (1.17 - 1.25)* | 1.31 (1.23 - 1.38)* |
Type of industry | ||
Technology | - | 1.00 |
Transportation | - | 1.44 (1.36 - 1.52)* |
Financial | - | 0.93 (0.88 - 0.98)* |
Manufacture | - | 1.07 (1.00 - 1.14)* |
Consumer | - | 1.07 (1.01 - 1.13)* |
Government | - | 1.57 (1.47 - 1.67)* |
Healthcare | - | 0.81 (0.75 - 0.87)* |
Other | - | 1.07 (1.02 - 1.12)* |
Wage (per 100,000 2014 US$) | - | 0.94 (0.90 - 0.98)* |
Comorbidities | ||
Venous thromboembolism | 13.50 (6.82 - 26.72)* | 22.12 (7.77 - 62.93)* |
Systemic lupus erythematosus | 1.90 (1.58 - 2.28)* | 1.92 (1.42 - 2.59)* |
Epilepsy | 1.92 (1.02 - 3.60)* | 1.39 (0.45 - 4.31) |
Hypertension | 1.55 (1.48 - 1.63)* | 1.63 (1.51 - 1.75)* |
Obesity | 1.54 (1.46 - 1.64)* | 1.64 (1.50 - 1.79)* |
Asthma | 1.25 (1.19 - 1.31)* | 1.30 (1.19 - 1.41)* |
Diabetes | 1.17 (1.09 - 1.26)* | 1.21 (1.08 - 1.36)* |
Rheumatoid arthritis | 1.19 (1.04 - 1.35)* | 1.22 (0.97 - 1.54) |
Inflammatory bowel disease | 1.09 (0.95 - 1.24) | 1.17 (0.94 - 1.45) |
Hypothyroidism | 1.05 (1.00 - 1.10)* | 1.12 (1.04 - 1.21)* |
Gynecology history | ||
History of SARC use | 0.08 (0.08 - 0.08)* | 0.07 (0.07 - 0.07)* |
History of LARC use | 254.14 (248.85 - 259.55)* | 310.20 (297.55 - 323.39)* |
History of obstetrician/gynecologist visits | 1.75 (1.72 - 1.78)* | 1.79 (1.74 - 1.85)* |
Pregnancy history | 2.80 (2.74 - 2.85)* | 2.32 (2.24 - 2.41)* |
Abortion history | 0.98 (0.94 - 1.01) | 0.93 (0.87 - 1.00)* |
Nulliparous status | ||
Nulliparous | 1.00 | 1.00 |
Non nulliparous | 2.29 (2.24 - 2.34)* | 2.56 (2.48 - 2.64)* |
Unknown nulliparous status | 1.30 (1.15 - 1.47)* | - |